Protagonist Therapeutics Inc (PTGX) — Capital Reinvestment Ratio
Protagonist Therapeutics Inc (PTGX) has a Capital Reinvestment Ratio of 0.00x as of March 2025, meaning it reinvests 0% of its operating cash flow ($125.36 Million) in capital expenditures ($545.00K). Check PTGX tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Protagonist Therapeutics Inc Capital Reinvestment Ratio (2017–2024)
This chart tracks Protagonist Therapeutics Inc's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see Protagonist Therapeutics Inc cash flow conversion.
Annual Capital Reinvestment Ratio for Protagonist Therapeutics Inc (2017–2024)
Year-by-year Capital Reinvestment Ratio for Protagonist Therapeutics Inc from 2017 to 2024. See PTGX FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.01x | $184.15 Million | $1.35 Million | ▼ -95.7% |
| 2017 | 0.17x | $3.87 Million | $666.00K | — |